Shattuck Historical Financial Ratios

STTK Stock

USD 1.30 0.05 4.00%

Shattuck Labs is promptly reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.65, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 4.4 will help investors to properly organize and evaluate Shattuck Labs financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.

About Shattuck Financial Ratios Analysis

Shattuck LabsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Shattuck Labs investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Shattuck financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Shattuck Labs history.

Shattuck Labs Financial Ratios Chart

At this time, Shattuck Labs' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.27 this year, although the value of Operating Cash Flow Per Share will most likely fall to (2.00).

Price To Sales Ratio Ev To Sales Payables Turnover Capex To Revenue

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Shattuck Labs stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Shattuck Labs sales, a figure that is much harder to manipulate than other Shattuck Labs multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most ratios from Shattuck Labs' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Shattuck Labs current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shattuck Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.At this time, Shattuck Labs' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.27 this year, although the value of Operating Cash Flow Per Share will most likely fall to (2.00).

	2021	2022	2023	2024 (projected)
Current Ratio	11.72	7.39	12.51	7.66
Net Debt To EBITDA	2.1	0.43	1.39	1.32

Current Ratio Net Debt To E B I T D A

Shattuck Labs fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Net Income Per Share	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield
Price To Sales Ratio		0.84	0.69	-0.46	-0.72	-0.87	0.84	0.9	-0.67	-0.82	-0.76	-0.21	0.31	0.15	0.35	0.59	0.89	0.26	-0.06	-0.37	-0.82	0.33	0.36	-0.69	0.24	-0.49
Ptb Ratio	0.84		0.94	-0.54	-0.84	-0.57	1.0	0.73	-0.83	-0.95	-0.81	-0.47	0.35	0.43	0.58	0.51	0.72	0.49	0.47	0.15	-0.95	0.56	0.56	-0.54	0.48	-0.55
Book Value Per Share	0.69	0.94		-0.43	-0.67	-0.36	0.94	0.69	-0.67	-0.81	-0.6	-0.31	0.3	0.65	0.39	0.27	0.56	0.31	0.59	0.38	-0.81	0.38	0.37	-0.28	0.3	-0.42
Free Cash Flow Yield	-0.46	-0.54	-0.43		0.81	0.15	-0.54	-0.26	0.85	0.69	0.81	0.66	-0.95	0.07	-0.71	-0.18	-0.2	-0.68	-0.32	0.02	0.69	-0.7	-0.71	0.58	-0.67	1.0
Operating Cash Flow Per Share	-0.72	-0.84	-0.67	0.81		0.5	-0.84	-0.44	1.0	0.96	0.99	0.79	-0.59	-0.01	-0.88	-0.63	-0.59	-0.83	-0.4	0.0	0.96	-0.87	-0.88	0.76	-0.82	0.82
Capex To Depreciation	-0.87	-0.57	-0.36	0.15	0.5		-0.57	-0.77	0.42	0.57	0.57	0.15	0.03	0.22	-0.25	-0.69	-0.96	-0.16	0.28	0.55	0.58	-0.22	-0.27	0.77	-0.13	0.2
Pb Ratio	0.84	1.0	0.94	-0.54	-0.84	-0.57		0.73	-0.83	-0.95	-0.81	-0.47	0.35	0.43	0.58	0.51	0.72	0.49	0.47	0.15	-0.95	0.56	0.56	-0.54	0.48	-0.55
Ev To Sales	0.9	0.73	0.69	-0.26	-0.44	-0.77	0.73		-0.39	-0.6	-0.47	0.11	0.2	0.31	0.02	0.35	0.81	-0.1	-0.1	-0.26	-0.6	-0.02	0.02	-0.44	-0.12	-0.28
Free Cash Flow Per Share	-0.67	-0.83	-0.67	0.85	1.0	0.42	-0.83	-0.39		0.95	0.98	0.81	-0.64	-0.03	-0.89	-0.57	-0.52	-0.85	-0.45	-0.05	0.95	-0.88	-0.88	0.73	-0.84	0.85
Roic	-0.82	-0.95	-0.81	0.69	0.96	0.57	-0.95	-0.6	0.95		0.95	0.65	-0.46	-0.22	-0.76	-0.65	-0.68	-0.7	-0.4	-0.03	1.0	-0.75	-0.75	0.67	-0.69	0.7
Net Income Per Share	-0.76	-0.81	-0.6	0.81	0.99	0.57	-0.81	-0.47	0.98	0.95		0.75	-0.6	0.06	-0.85	-0.66	-0.62	-0.8	-0.27	0.14	0.94	-0.84	-0.85	0.8	-0.79	0.83
Payables Turnover	-0.21	-0.47	-0.31	0.66	0.79	0.15	-0.47	0.11	0.81	0.65	0.75		-0.45	0.3	-0.98	-0.48	-0.25	-0.98	-0.61	-0.27	0.65	-0.98	-0.98	0.67	-0.97	0.66
Capex To Revenue	0.31	0.35	0.3	-0.95	-0.59	0.03	0.35	0.2	-0.64	-0.46	-0.6	-0.45		-0.06	0.47	-0.09	0.01	0.46	0.22	-0.03	-0.47	0.46	0.48	-0.39	0.45	-0.94
Cash Per Share	0.15	0.43	0.65	0.07	-0.01	0.22	0.43	0.31	-0.03	-0.22	0.06	0.3	-0.06		-0.24	-0.23	-0.07	-0.26	0.37	0.47	-0.22	-0.22	-0.28	0.52	-0.24	0.11
Pocfratio	0.35	0.58	0.39	-0.71	-0.88	-0.25	0.58	0.02	-0.89	-0.76	-0.85	-0.98	0.47	-0.24		0.59	0.35	0.99	0.55	0.18	-0.76	1.0	1.0	-0.72	0.99	-0.71
Interest Coverage	0.59	0.51	0.27	-0.18	-0.63	-0.69	0.51	0.35	-0.57	-0.65	-0.66	-0.48	-0.09	-0.23	0.59		0.65	0.56	-0.07	-0.24	-0.65	0.59	0.59	-0.66	0.56	-0.23
Capex To Operating Cash Flow	0.89	0.72	0.56	-0.2	-0.59	-0.96	0.72	0.81	-0.52	-0.68	-0.62	-0.25	0.01	-0.07	0.35	0.65		0.24	-0.02	-0.32	-0.68	0.31	0.36	-0.78	0.21	-0.24
Pfcf Ratio	0.26	0.49	0.31	-0.68	-0.83	-0.16	0.49	-0.1	-0.85	-0.7	-0.8	-0.98	0.46	-0.26	0.99	0.56	0.24		0.53	0.19	-0.69	1.0	0.99	-0.66	1.0	-0.69
Days Payables Outstanding	-0.06	0.47	0.59	-0.32	-0.4	0.28	0.47	-0.1	-0.45	-0.4	-0.27	-0.61	0.22	0.37	0.55	-0.07	-0.02	0.53		0.87	-0.4	0.54	0.52	-0.04	0.52	-0.27
Income Quality	-0.37	0.15	0.38	0.02	0.0	0.55	0.15	-0.26	-0.05	-0.03	0.14	-0.27	-0.03	0.47	0.18	-0.24	-0.32	0.19	0.87		-0.04	0.19	0.15	0.36	0.2	0.08
Roe	-0.82	-0.95	-0.81	0.69	0.96	0.58	-0.95	-0.6	0.95	1.0	0.94	0.65	-0.47	-0.22	-0.76	-0.65	-0.68	-0.69	-0.4	-0.04		-0.75	-0.75	0.68	-0.68	0.7
Ev To Operating Cash Flow	0.33	0.56	0.38	-0.7	-0.87	-0.22	0.56	-0.02	-0.88	-0.75	-0.84	-0.98	0.46	-0.22	1.0	0.59	0.31	1.0	0.54	0.19	-0.75		1.0	-0.68	0.99	-0.7
Pe Ratio	0.36	0.56	0.37	-0.71	-0.88	-0.27	0.56	0.02	-0.88	-0.75	-0.85	-0.98	0.48	-0.28	1.0	0.59	0.36	0.99	0.52	0.15	-0.75	1.0		-0.74	0.98	-0.71
Return On Tangible Assets	-0.69	-0.54	-0.28	0.58	0.76	0.77	-0.54	-0.44	0.73	0.67	0.8	0.67	-0.39	0.52	-0.72	-0.66	-0.78	-0.66	-0.04	0.36	0.68	-0.68	-0.74		-0.62	0.61
Ev To Free Cash Flow	0.24	0.48	0.3	-0.67	-0.82	-0.13	0.48	-0.12	-0.84	-0.69	-0.79	-0.97	0.45	-0.24	0.99	0.56	0.21	1.0	0.52	0.2	-0.68	0.99	0.98	-0.62		-0.67
Earnings Yield	-0.49	-0.55	-0.42	1.0	0.82	0.2	-0.55	-0.28	0.85	0.7	0.83	0.66	-0.94	0.11	-0.71	-0.23	-0.24	-0.69	-0.27	0.08	0.7	-0.7	-0.71	0.61	-0.67

Click cells to compare fundamentals

Shattuck Labs Account Relationship Matchups

Shattuck Labs fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	81.7	220.36	11.92	149.5	183.31	192.47
Ptb Ratio	(23.38)	7.06	1.32	0.55	2.1	2.2
Book Value Per Share	(0.83)	7.42	6.47	4.16	3.4	2.65
Free Cash Flow Yield	(0.0265)	(0.0157)	(0.18)	(1.09)	(0.27)	(0.28)
Operating Cash Flow Per Share	(0.5)	(0.81)	(1.36)	(2.23)	(1.91)	(2.0)
Stock Based Compensation To Revenue	0.0466	0.13	0.18	9.91	4.19	4.4
Capex To Depreciation	0.88	1.18	5.74	3.78	0.1	0.0957
Pb Ratio	(23.38)	7.06	1.32	0.55	2.1	2.2
Ev To Sales	80.99	204.46	8.84	83.27	110.03	66.55
Free Cash Flow Per Share	(0.51)	(0.82)	(1.55)	(2.5)	(1.92)	(2.01)
Roic	0.72	(0.12)	(0.16)	(0.58)	(0.64)	(0.6)
Net Income Per Share	(0.57)	(0.85)	(1.06)	(2.37)	(2.05)	(2.15)
Payables Turnover	9.51	21.37	0.14	0.47	2.55	2.42
Sales General And Administrative To Revenue	0.58	0.94	0.62	32.33	11.65	6.18
Research And Ddevelopement To Revenue	2.96	3.77	1.88	127.15	44.85	24.22
Capex To Revenue	0.0475	0.0732	0.26	17.81	0.25	0.23
Cash Per Share	0.94	8.03	6.4	3.81	3.07	3.5
Pocfratio	(38.51)	(65.04)	(6.26)	(1.03)	(3.74)	(3.93)
Capex To Operating Cash Flow	(0.0224)	(0.0216)	(0.14)	(0.12)	(0.005011)	(0.005261)
Pfcf Ratio	(37.67)	(63.66)	(5.5)	(0.92)	(3.72)	(3.91)
Days Payables Outstanding	38.4	17.08	2.6K	775.42	143.31	136.14
Ev To Operating Cash Flow	(38.18)	(60.34)	(4.65)	(0.57)	(2.24)	(2.36)
Pe Ratio	(33.82)	(61.77)	(8.07)	(0.97)	(3.48)	(3.65)
Return On Tangible Assets	(0.53)	(0.1)	(0.15)	(0.49)	(0.55)	(0.57)
Ev To Free Cash Flow	(37.34)	(59.07)	(4.08)	(0.51)	(2.23)	(2.34)
Earnings Yield	(0.0296)	(0.0162)	(0.12)	(1.03)	(0.29)	(0.3)
Net Debt To E B I T D A	0.29	4.35	2.1	0.43	1.39	1.32
Current Ratio	2.12	20.53	11.72	7.39	12.51	7.66
Tangible Book Value Per Share	(0.83)	7.42	6.47	4.16	3.4	2.65
Graham Number	3.26	11.9	12.39	14.9	12.51	7.71
Shareholders Equity Per Share	(0.83)	7.42	6.47	4.16	3.4	2.65
Capex Per Share	0.0113	0.0174	0.19	0.27	0.009554	0.009076
Graham Net Net	(0.97)	7.09	5.76	3.12	2.72	2.19
Enterprise Value Over E B I T D A	(32.64)	(55.93)	(6.05)	(0.54)	(2.08)	(2.18)
Price Earnings Ratio	(33.82)	(61.77)	(8.07)	(0.97)	(3.48)	(3.65)
Price Book Value Ratio	(23.38)	7.06	1.32	0.55	2.1	2.2

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Shattuck Labs is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Shattuck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Shattuck Labs Stock. Highlighted below are key reports to facilitate an investment decision about Shattuck Labs Stock:

How To Invest In Shattuck

Details

Is Shattuck Stock a good investment?

Details

What is Shattuck Labs' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.53)

Revenue Per Share

0.088

Quarterly Revenue Growth

7.045

Return On Assets

(0.40)

Return On Equity

(0.68)

The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Shattuck Historical Financial Ratios

About Shattuck Financial Ratios Analysis

Shattuck Labs Financial Ratios Chart

Price To Sales Ratio

Ev To Sales

Payables Turnover

Capex To Revenue

Shattuck Labs fundamentals Correlations

Shattuck Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shattuck Labs fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Earnings Yield	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Roe	+ 1.0	Roic
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Pe Ratio	+ 1.0	Pocfratio

Pe Ratio	- 0.98	Payables Turnover
Ev To Operating Cash Flow	- 0.98	Payables Turnover
Pfcf Ratio	- 0.98	Payables Turnover
Pocfratio	- 0.98	Payables Turnover
Ev To Free Cash Flow	- 0.97	Payables Turnover
Capex To Operating Cash Flow	- 0.96	Capex To Depreciation